Bibliographic Details
| Title: |
Circulating cell-free DNA methylation analysis of pancreatic cancer patients for early noninvasive diagnosis |
| Authors: |
Wenzhe Hu, Xudong Zhao, Nan Luo, Mengmeng Xiao, Feng Feng, Yuan An, Jianfei Chen, Long Rong, Yinmo Yang, Jirun Peng |
| Source: |
Frontiers in Oncology, Vol 15 (2025) |
| Publisher Information: |
Frontiers Media S.A., 2025. |
| Publication Year: |
2025 |
| Collection: |
LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
| Subject Terms: |
circulating cell-free DNA, DNA methylation, pancreatic cancer, early noninvasive diagnosis, hepatocellular carcinoma, colorectal cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282 |
| More Details: |
BackgroundAberrant hypermethylation of genomic DNA CpG islands (CGIs) is frequently observed in human pancreatic cancer (PAC). A plasma cell-free DNA (cfDNA) methylation analysis method can be utilized for the early and noninvasive detection of PAC. This study also aimed to differentiate PAC from other cancer types.MethodsWe employed the methylated CpG tandem amplification and sequencing (MCTA-Seq) method, which targets approximately one-third of CGIs, on plasma samples from PAC patients (n = 50) and healthy controls (n = 52), as well as from cancerous and adjacent noncancerous tissue samples (n = 66). The method’s efficacy in detecting PAC and distinguishing it from hepatocellular carcinoma (HCC), colorectal cancer (CRC), and gastric cancer (GC) was evaluated. Additionally, a methylation score and typing system for PAC was also established.ResultsWe identified a total of 120 cfDNA methylation biomarkers, including IRX4, KCNS2, and RIMS4, for the detection of PAC in blood. A panel comprising these biomarkers achieved a sensitivity of 97% and 86% for patients in the discovery and validation cohorts, respectively, with a specificity of 100% in both cohorts. The methylation scoring and typing systems were clinically applicable. Furthermore, we identified hundreds of differentially methylated cfDNA biomarkers between PAC and HCC, CRC, and GC. Certain combinations of these markers can be used in a highly specific (approximately 100%) algorithm to differentiate PAC from HCC, CRC, and GC in blood.ConclusionsOur study identified cfDNA methylation markers for PAC, offering a novel approach for the early, noninvasive diagnosis of PAC. |
| Document Type: |
article |
| File Description: |
electronic resource |
| Language: |
English |
| ISSN: |
2234-943X |
| Relation: |
https://www.frontiersin.org/articles/10.3389/fonc.2025.1552426/full; https://doaj.org/toc/2234-943X |
| DOI: |
10.3389/fonc.2025.1552426 |
| Access URL: |
https://doaj.org/article/c9cd107113214cf994e37263e5d675b8 |
| Accession Number: |
edsdoj.9cd107113214cf994e37263e5d675b8 |
| Database: |
Directory of Open Access Journals |
